Abstract
Objectives: This study was conducted in order to assess the efficacy of 1st generation cephalosporin as use as a single-dose preoperative prophylactic antibiotic for surgical wound infections resulting from intra-oral bone grafting procedures. Materials and Methods: A total of 23 patients who were to undergo intra-oral bone graft procedures participated in this study. After randomization, 2 grams of 1st generation cephalosporin was orally administered to both the experimental and placebo groups one hour prior to surgery in a double-blind fashion. Post-operatively, the experimental group (12 patients) was orally administered placebo three times a day for three days. The control group (11 patients) was orally administered 1st generation cephalosporin three times a day for three days. The postoperative course was observed for one month including the clinical parameters associated with infection. Results: Postoperative infections were noted in 1 out of 12 patients in the experimental group. No infections occurred in the control group. Conclusion: There was no significant difference in the incidence of postoperative infections between the two groups. Two grams of 1st generation cephalosporin administered orally one hour before surgery served as an effective prophylactic antibiotics therapy for intra-oral bone graft surgery.
Introduction
In dental implantology, bone grafting is a routine procedure used to provide adequate volume for implant placement. However, the oral cavity is a non-sterile environment, making Surgical Site Infections (SSIs) a significant risk. Infections can lead to pain, bone resorption, and graft failure. Currently, many oral surgeons lack standardized guidelines and often prescribe multi-day postoperative antibiotic courses based on personal experience. This practice contributes to antimicrobial resistance and unnecessary healthcare costs. This study investigates whether a single preoperative "loading dose" is as effective as a multi-day postoperative regimen.
Methods
The researchers conducted a randomized, prospective, double-blind clinical trial at Seoul National University Dental Hospital. Initially, 31 patients were randomized, with 23 patients completing the trial after exclusions for systemic disease or pre-existing infections.
All patients received 2 grams of a first-generation cephalosporin orally one hour before surgery. Following the procedure:
- Control Group (n=11): Received 1 gram of antibiotics three times a day for three days.
- Experimental Group (n=12): Received a placebo on the same schedule.
Patients were monitored for one month for clinical signs of infection (pain, swelling, fever) and biological markers (WBC, CRP, and ESR).
Results
The study found no statistically significant difference ($P > 0.05$) between the two groups regarding infection rates or clinical markers. Only one patient in the experimental group (8.3%) developed a minor infection, which was successfully treated with drainage. No infections occurred in the control group.
Clinical parameters such as body temperature and inflammatory markers remained within normal ranges for both cohorts throughout the follow-up period.
Discussion and Conclusion
The findings suggest that the most critical period for antibiotic prophylaxis is during the surgical procedure itself. Maintaining high tissue concentrations of the drug at the time of the initial incision prevents bacterial colonization. Notably, instances of wound dehiscence in the experimental group healed naturally without infection, suggesting that mechanical healing issues do not always necessitate antibiotic intervention.
While limited by a small sample size ($n=23$) and a focus on autogenous grafts, this trial provides evidence that a single 2g preoperative dose of first-generation cephalosporin is sufficient for intra-oral bone graft surgery. This approach could significantly reduce antibiotic overuse in dental practice. Future multi-center trials with larger populations and various graft materials (xenografts or synthetics) are recommended to establish a formal clinical standard.
Summary updated